Trials / Recruiting
RecruitingNCT07017699
A Study to Assess Deucravacitinib Safety in Pregnancy
The Deucravacitinib Pregnancy Exposure Study: A Prospective Observational Study of Deucravacitinib Safety in Pregnancy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 900 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess pregnancy and infant outcomes among pregnant participants enrolled in an established North American pregnancy registry (Organization of Teratology Information Specialists \[OTIS\]) who were exposed to deucravacitinib.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Deucravacitinib | According to product label |
| DRUG | Other systemic treatments for PsO | According to product label |
Timeline
- Start date
- 2025-03-21
- Primary completion
- 2028-04-01
- Completion
- 2029-02-28
- First posted
- 2025-06-12
- Last updated
- 2025-06-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07017699. Inclusion in this directory is not an endorsement.